Beijing: The CDC (Chinese Center for Disease Control & Prevention ) on Sunday confirmed that China has so far administered more than 24 million doses of COVID-19 vaccines, and the reported rate of severe adverse effects rate is no higher than flu shots.

Since  China is encountering a complicated epidemic control situation, registering 2,016 domestically transmitted COVID-19 cases in January, which is marked to be the highest since March 2020,  observers noted that pushing forward steadily with the vaccination program can help reduce epidemic risks. Meantime, Some Chinese authorities have said China was planning to vaccinate 50 million people before the Chinese New Year to curb the spread of the virus.

Last month, an inactivated vaccine called the CoronaVac developed by Beijing Biological Products Institute Co., Ltd. under the China National Biotec Group (CNBG), affiliated with Sinopharm, became the first to receive conditional market approval from the National Medical Products Administration.

It works by using killed viral particles to expose the body's immune system to the virus without risking a serious disease response.

Since the onset of the pandemic late 2019, China has so far registered a total of 89,564 coronavirus cases and 4,636 deaths.

Experts noted the low adverse effect rate proved the safety of Chinese COVID-19 vaccines and should encourage more people to get the shot. China's vaccination drive is going smoothly and orderly, and the target for immunity can be met.

Protest outside China embassy in France against Tibetan monk's brutal killing

Corona Update: Thailand confirms 829 new corona cases

Russia registers 18,359 fresh corona cases in last 24 hours